Uncategorized
Legend scientific founder returns to ASCO with new ambition for high-yield, non-gene-editing CAR-T platform
Nine years after wowing the audience at the American Society of Clinical Oncology annual meeting with a CAR-T candidate that would become Carvykti—now the world’s most successful cell therapy—Legend Biotech’s scientific founder Frank Fan, M.D., Ph.D., is returning to the spotlight with an entirely new playbook.Read More
Nine years after wowing the audience at the American Society of Clinical Oncology annual meeting with a CAR-T candidate that would become Carvykti—now the world’s most successful cell therapy—Legend Biotech’s scientific founder Frank Fan, M.D., Ph.D., is returning to the spotlight with an entirely new playbook.Read More